Quanta Therapeutics secures Series D extension financing to advance KRAS inhibitor programs through clinical milestones.
Round Type
Series D
Description
Quanta Therapeutics announced the completion of a Series D extension financing round that provides funding through key clinical data readouts. The company presented positive clinical combination data for its lead program QTX3034 in KRAS G12D-mutant colorectal cancer at ESMO Congress 2026. Quanta is advancing QTX6255, a potential best-in-class pan-KRAS inhibitor, toward an IND filing in Q4 2026 with Phase 1 trials anticipated in early 2027. The extension round strengthens the company's cash position to support these critical development milestones.
Quick answer
Quanta Therapeutics raised an undisclosed amount in a Series D round, dated October 24, 2026.
- How much did Quanta Therapeutics raise?
- Quanta Therapeutics raised an undisclosed amount in a Series D round on October 24, 2026.
- What does Quanta Therapeutics do?
- Quanta Therapeutics is a privately held, clinical-stage biopharmaceutical company leading the development of innovative therapeutics for RAS-driven cancers.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Quanta Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
- Breye Therapeutics raised $77M (Series A) on September 29, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
Who to call at Quanta Therapeutics, and when
A new round usually means Quanta Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Quanta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quanta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quanta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quanta Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Quanta Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.